News Digest / Income Statements / Celestica Posts Strong Q2 2025 Growth Amid Rising Costs and Strategic R&D Investment

Celestica Posts Strong Q2 2025 Growth Amid Rising Costs and Strategic R&D Investment

StockInvest.us
05:02pm, Monday, Jul 28, 2025
Illustration by StockInvest.us

Celestica Inc. (NYSE: CLS) recently provided its Q2 2025 financial results, showcasing significant growth and operational developments.

Positive Aspects:

  • Revenue Growth: Revenue for Q2 2025 reached $2.89 billion, a 21% increase compared to $2.39 billion in Q2 2024. Total revenue for the first half of 2025 was $5.54 billion, up 20% year-over-year.
  • Increased Gross Profit: Gross profit rose by 46% to $371 million in Q2 2025 from $254 million in Q2 2024.
  • Cost Reduction in SG&A: Selling, General and Administrative (SG&A) expenses dropped by 51% to $39 million compared to $79 million in Q2 2024.
  • Net Earnings: Net earnings soared to $211 million, more than doubling from $95 million in Q2 2024, leading to a diluted earnings per share of $1.82.

Negative Aspects:

  • Cash Position Decrease: Cash and cash equivalents fell to $313.8 million, down from $423.3 million at year-end 2024.
  • Increased Research and Development Expenses: R&D expenses increased to $34 million in Q2 2025 from $19 million in Q2 2024, driven by strategic growth initiatives in the AI and HPS segments.
  • Higher Tax Expenses: Income tax expense notably increased to $46.3 million in Q2 2025 from $18.5 million in Q2 2024, impacting net earnings.

Key Statistics:

  • Total Assets: $6.24 billion (as of June 30, 2025) versus $5.99 billion (December 31, 2024).
  • Operating Cash Flow: $152.4 million in Q2 2025, up from $99.6 million in Q2 2024.
  • Segment Margins: ATS segment margin was 5.3% (up from 4.6%); CCS segment margin rose to 8.3% (up from 7.0%).
  • Common Shares Repurchased: The company spent $40 million to repurchase 0.6 million shares as part of its NCIB program.

In summary, Celestica Inc. (NYSE: CLS) reported notable revenue and earnings growth for Q2 2025, with substantial improvements in gross profit and operational efficiency. However, increasing cash outflows and higher tax liabilities raise concerns for investors. Further investments in R&D reflect the company's long-term growth strategy, particularly within the burgeoning AI landscape.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.